Interesting downstream effect of the flooding. Apparently Milton clobbered a Baxter plant that makes something like 60% of the sterile IV fluids in the US, which has led to a severe supply chain crunch. (Some health care facilities are actually exploring "take back" programs from patients who have excess product that could be restockable.) Lots of elective procedures being delayed.
Crazy that our iv fluid supply chain is so tight, but it's nothing new -- several years back one of the major suppliers had big fda manufacturing problems that created a crunch that lasted for years. This is what happens when you have commodity products for which the payor margins have been squeezed so tight - the suppliers abandon the market and apply their manufacturing capacity to make other products and when something goes boom, well, we get screwed. (Interestingly, I've noted elsewhere how the IRA's 'negotiated pricing' standards essentially remove any margin opportunities for pharmacies to dispense the products subject to the negotiated prices -- heard for the first time yesterday that some pharmacies are basically just not going to stock those products, or will stock only minimal inventory, so that patients will have to go elsewhere.)